Joanna Strand

639 total citations
26 papers, 511 citations indexed

About

Joanna Strand is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joanna Strand has authored 26 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Joanna Strand's work include Radiopharmaceutical Chemistry and Applications (21 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Prostate Cancer Treatment and Research (6 papers). Joanna Strand is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (21 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Prostate Cancer Treatment and Research (6 papers). Joanna Strand collaborates with scholars based in Sweden, Iran and Finland. Joanna Strand's co-authors include Vladimir Tolmachev, Anna Orlova, Hadis Honarvar, Amelie Eriksson Karlström, Mohamed Altai, Ram Kumar Selvaraju, Zohreh Varasteh, Anna Perols, Torbjörn Gräslund and Camilla Hofström and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Joanna Strand

22 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Strand Sweden 14 431 259 149 72 30 26 511
Erasmus Poku United States 14 419 1.0× 302 1.2× 156 1.0× 97 1.3× 26 0.9× 33 660
Jennie Malmberg Sweden 11 398 0.9× 224 0.9× 136 0.9× 74 1.0× 18 0.6× 12 460
Anne-Line Anderson United States 9 416 1.0× 174 0.7× 168 1.1× 70 1.0× 29 1.0× 11 521
Kristin McLarty Canada 12 400 0.9× 267 1.0× 130 0.9× 66 0.9× 11 0.4× 15 516
Maria� Rosestedt Sweden 11 307 0.7× 222 0.9× 128 0.9× 69 1.0× 8 0.3× 20 415
Marjolijn N. Lub‐de Hooge Netherlands 12 345 0.8× 274 1.1× 129 0.9× 69 1.0× 11 0.4× 25 516
Hadis Honarvar Sweden 20 698 1.6× 404 1.6× 309 2.1× 96 1.3× 73 2.4× 30 861
Leslie Wetzel United States 7 297 0.7× 459 1.8× 188 1.3× 83 1.2× 29 1.0× 11 661
Kelly Davis Orcutt United States 13 334 0.8× 155 0.6× 201 1.3× 40 0.6× 23 0.8× 25 510
Sara S. Rinne Sweden 19 541 1.3× 351 1.4× 202 1.4× 158 2.2× 19 0.6× 44 676

Countries citing papers authored by Joanna Strand

Since Specialization
Citations

This map shows the geographic impact of Joanna Strand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Strand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Strand more than expected).

Fields of papers citing papers by Joanna Strand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Strand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Strand. The network helps show where Joanna Strand may publish in the future.

Co-authorship network of co-authors of Joanna Strand

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Strand. A scholar is included among the top collaborators of Joanna Strand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Strand. Joanna Strand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Daniel, Evangelia Sereti, Michael Gottschalk, et al.. (2024). Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting. PLoS ONE. 19(7). e0307558–e0307558. 2 indexed citations
2.
Örbom, Anders, et al.. (2024). Intratumoral Distribution of [ 177 Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer. Cancer Biotherapy and Radiopharmaceuticals. 40(3). 219–227.
3.
Roth, Daniel, et al.. (2024). Feasibility of 177Lu activity quantification using a small portable CZT-based gamma-camera. EJNMMI Physics. 11(1). 2–2.
4.
Strand, Joanna, et al.. (2022). Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617. Pharmaceutics. 14(4). 731–731. 9 indexed citations
6.
Westerlund, Kristina, Hadis Honarvar, Joanna Strand, et al.. (2016). Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules. Molecular Pharmaceutics. 13(5). 1668–1678. 40 indexed citations
7.
Strand, Joanna, Patrik Nordeman, Hadis Honarvar, et al.. (2015). Site‐Specific Radioiodination of HER2‐Targeting Affibody Molecules using 4‐Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity. ChemistryOpen. 4(2). 174–182. 16 indexed citations
8.
Strand, Joanna, Zohreh Varasteh, Olof Eriksson, et al.. (2014). Gallium-68-labeled affibody molecule for PET imaging of PDGFR beta expression in vivo. European Journal of Nuclear Medicine and Molecular Imaging. 41. 8 indexed citations
9.
Altai, Mohamed, Helena Wållberg, Hadis Honarvar, et al.. (2014). 188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment. Journal of Nuclear Medicine. 55(11). 1842–1848. 23 indexed citations
10.
Altai, Mohamed, Hadis Honarvar, Helena Wållberg, et al.. (2014). Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re. European Journal of Medicinal Chemistry. 87. 519–528. 19 indexed citations
11.
Orlova, Anna, Magdalena Malm, Maria� Rosestedt, et al.. (2014). Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule. European Journal of Nuclear Medicine and Molecular Imaging. 41(7). 1450–1459. 42 indexed citations
12.
Strand, Joanna, Zohreh Varasteh, Olof Eriksson, et al.. (2014). Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo. Molecular Pharmaceutics. 11(11). 3957–3964. 49 indexed citations
13.
Strand, Joanna, Hadis Honarvar, Anna Perols, et al.. (2013). Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts. PLoS ONE. 8(8). e70028–e70028. 50 indexed citations
15.
Rosik, Daniel, Alf Thibblin, Gunnar Antoni, et al.. (2013). Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with 18F-4-Fluorobenzaldehyde. Bioconjugate Chemistry. 25(1). 82–92. 28 indexed citations
16.
Honarvar, Hadis, Anna Perols, Joanna Strand, et al.. (2012). Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules. European Journal of Nuclear Medicine and Molecular Imaging. 39. 1 indexed citations
17.
Altai, Mohamed, Joanna Strand, Daniel Rosik, et al.. (2012). Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA. European Journal of Nuclear Medicine and Molecular Imaging. 39.
18.
Perols, Anna, Hadis Honarvar, Joanna Strand, et al.. (2012). Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules. Bioconjugate Chemistry. 23(8). 1661–1670. 38 indexed citations
19.
Evans‐Axelsson, Susan, David Ulmert, Anders Örbom, et al.. (2012). Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone. Cancer Biotherapy and Radiopharmaceuticals. 27(4). 243–251. 11 indexed citations
20.
Orlova, Anna, Camilla Hofström, Joanna Strand, et al.. (2012). [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. European Journal of Nuclear Medicine and Molecular Imaging. 40(3). 439–449. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026